Gregory M. Fahy is the Chief Scientific Officer of 21st Century Medicine. He was the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program of the U.S. Naval Medical Research Institute in Bethesda, Maryland, and he has served as the Chief Scientific Officer of Organ, Inc, LRT, Inc., Longevity Bridge, Inc., and Intervene Immune, Inc. He was the director of organ cryopreservation research at the American National Red Cross' Transplantation Laboratory and Blood Research Laboratory in Maryland for 20 years and has been the CSO of 21st Century Medicine since 2001, before that serving as the company's VP for Cryopreservation Research and as its Director of Research from 1999-2001. Dr. Fahy has been the VP of 21st Century Medicine since 1999 and has been a director since 1999. He has also served on the Board of Xytex Research, Inc, and Intervene Immune, Inc. and directed a successful human clinical trial.

Brian G. Wowk is the Chief Technology Officer of 21st Century Medicine and is responsible for developing a variety of cryobiological technologies. He was the discoverer of the ice-blocking properties of the Supercool X-1000 product and was able to define the antinucleation properties of our Supercool Z-1000 product and demonstrate the synergistic effects of these two ice blockers. He is the co-inventor of M22 and the inventor of our CIVS technology for storing samples at temperatures between the glass transition temperature and typical liquid nitrogen vapor storage temperatures. He is presently refining electromagnetic warming methods for vitrified whole organs.

Aschwin de Wolf is the CEO of Advanced Neural Biosciences. He was also the co-founder of the nonprofit Institute for Evidence-Based Cryonics, and is editor of the quarterly Cryonics magazine published by the Alcor Life Extension Foundation. He founded and regularly contributes to the online platform Biostasis, and frequently serves as cryonics consultant and advisor for domestic and global initiatives.